股本结构
单位：万股
| 公告日期 | 2024-04-18 | 2024-03-26 | 2024-03-26 | 2023-11-09 | 2023-11-09 | 2023-08-10 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3606.08 | 3009.82 | 1123.02 | 652.93 | 652.90 | 421.47 |
| 普通股本 | 3606.08 | 3009.82 | 1123.02 | 652.93 | 652.90 | 421.47 |
| 优先股 | 0.11 | 未披露 | 0.70 | 未披露 | 0.70 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-01 | 2024-03-21 | 2023-12-31 | 2023-11-06 | 2023-09-30 | 2023-08-07 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-18 | 3606.08 | 0.11 | 定期报告 | 2024-04-01 |
| 2024-03-26 | 3009.82 | 未披露 | 定期报告 | 2024-03-21 |
| 2024-03-26 | 1123.02 | 0.70 |
更多>>
From December 31,2022 to December 31,2023
Vesting of director restricted stock awards
Conversion of Series B Preferred Stock to common stock
Conversion of Series C Preferred Stock to common stock
Issuance of common stock in connection with 2023 Warrant Reprice Transaction, net of offering costs
|
2023-12-31 |
| 2023-11-09 | 652.93 | 未披露 | 定期报告 | 2023-11-06 |
| 2023-11-09 | 652.90 | 0.70 |
更多>>
From June 30, 2023 to September 30, 2023
Conversion of Series B Preferred Stock to common stock
|
2023-09-30 |
| 2023-08-10 | 421.47 | 未披露 | 定期报告 | 2023-08-07 |
| 2023-08-10 | 421.40 | 1.00 |
更多>>
From March 31, 2023 to June 30, 2023
Vesting of director restricted stock awards
Conversion of Series B Preferred Stock to common stock
Conversion of Series C Preferred Stock to common stock
|
2023-06-30 |
| 2023-05-31 | 420.95 | 1.03 | 定期报告 | 2023-05-24 |
| 2023-05-17 | 272.88 | 1.22 | 定期报告 | 2023-05-10 |
| 2023-05-18 | 272.88 | 未披露 | 定期报告 | 2023-05-05 |
| 2023-04-28 | 219.44 | 未披露 | 定期报告 | 2023-04-21 |
| 2023-03-31 | 203.54 | 未披露 | 定期报告 | 2023-03-27 |
| 2023-03-31 | 203.50 | 1.40 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of Series C Preferred Stock, net of offering costs
Vesting of director restricted stock awards
Shares issued for reverse stock split due to rounding feature
Issuance of common stock in connection with exercise of warrants, net of offering costs
Conversion of Series B Preferred Stock to common stock
Conversion of Series C Preferred Stock to common stock
|
2022-12-31 |
| 2022-12-16 | 187.64 | 未披露 | 定期报告 | 2022-12-07 |
| 2022-11-14 | 185.68 | 未披露 |
更多>>
NovaBay Pharmaceuticals, Inc. announces 1-for-35 reverse stock split.
|
2022-11-16 |
| 2022-11-14 | 6498.84 | 未披露 | 定期报告 | 2022-11-10 |
| 2022-11-14 | 6498.80 | 1.20 |
更多>>
From June 30, 2022 to September 30, 2022
Exercise of warrants, net of offering costs
|
2022-09-30 |
| 2022-09-30 | 6498.84 | 1.16 | 定期报告 | 2022-09-13 |
| 2022-08-11 | 5351.34 | 未披露 | 定期报告 | 2022-08-09 |
| 2022-08-11 | 5351.30 | 1.20 |
更多>>
From March 31, 2022 to June 30, 2022
Conversion of Series B Non-Voting Preferred Stock to common stock
Vesting of director restricted stock awards
|
2022-06-30 |
| 2022-05-12 | 5261.84 | 未披露 | 定期报告 | 2022-05-10 |
| 2022-05-12 | 5141.90 | 1.30 |
更多>>
From December 31, 2021 to March 31, 2022
Conversion of Series B Non-Voting Preferred Stock to common stock
|
2022-03-31 |
| 2022-03-29 | 5141.84 | 未披露 | 定期报告 | 2022-03-24 |
| 2022-03-30 | 5101.84 | 未披露 | 定期报告 | 2022-03-16 |
| 2022-02-04 | 4981.84 | 未披露 | 定期报告 | 2022-02-02 |
| 2022-03-29 | 4776.60 | 1.40 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock, net of offering costs
Vesting of employee restricted stock awards
Issuance of RSUs to non-employees for services
Issuance of Series B Preferred Stock and common stock warrants, net of offering costs
Conversion of Series B Preferred Stock to common stock
|
2021-12-31 |
| 2021-12-01 | 4495.84 | 未披露 | 定期报告 | 2021-11-26 |
| 2021-11-12 | 4494.34 | 未披露 | 定期报告 | 2021-10-25 |
| 2021-11-12 | 4494.30 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Vesting of employee restricted stock awards
|
2021-09-30 |
| 2021-08-12 | 4494.34 | 未披露 | 定期报告 | 2021-08-10 |
| 2021-08-12 | 4461.50 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock, net of offering costs
Vesting of employee restricted stock awards
|
2021-06-30 |
| 2021-05-14 | 4194.26 | 未披露 | 定期报告 | 2021-05-11 |
| 2021-05-06 | 4178.26 | 未披露 | 定期报告 | 2021-05-03 |
| 2021-05-06 | 4178.20 | 未披露 | 定期报告 | 2021-03-31 |
| 2021-03-26 | 4178.26 | 未披露 | 定期报告 | 2021-03-19 |
| 2021-03-25 | 4178.20 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock, net of offering costs
Issuance of common stock in connection with exercise of warrants, net
Issuance of RSUs to non-employees for services
Issuance of stock for option exercises
Vesting of employee restricted stock awards
|
2020-12-31 |
| 2020-11-12 | 4178.26 | 未披露 | 定期报告 | 2020-11-10 |
| 2020-11-12 | 4176.00 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock in connection with exercise of warrants, net
Issuance of RSUs to non-employees for services
Issuance of stock for option exercises
|
2020-09-30 |
| 2020-08-21 | 4173.99 | 未披露 | 定期报告 | 2020-08-14 |
| 2020-08-06 | 4173.99 | 未披露 | 定期报告 | 2020-08-04 |
| 2020-08-06 | 3464.80 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock, net of offering costs
Issuance of common stock in connection with exercise of warrants
|
2020-06-30 |
| 2020-06-15 | 3337.70 | 未披露 | 定期报告 | 2020-06-15 |
| 2020-05-07 | 2881.06 | 未披露 | 定期报告 | 2020-05-05 |
| 2020-04-27 | 2823.91 | 未披露 | 定期报告 | 2020-04-22 |
| 2020-05-07 | 2823.90 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock in connection with exercise of warrants, net of issuance cost
Vesting of employee restricted stock awards
|
2020-03-31 |
| 2020-03-26 | 2801.06 | 未披露 | 定期报告 | 2020-03-24 |
| 2020-03-26 | 2793.80 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of Series A Preferred Stock and common stock warrants, net of offering costs
Conversion of Series A Preferred Stock to common stock
Issuance of common stock in connection with offering, net of offering costs
Issuance of common stock in connection with exercise of warrants
Issuance of RSUs related to employee separation agreement
Issuance of common stock for option exercises
Issuance of RSUs to non-employees for services
Vesting of employee restricted stock awards
|
2019-12-31 |
| 2019-10-25 | 2790.19 | 未披露 | 定期报告 | 2019-10-14 |
| 2019-11-07 | 2520.20 | 270.00 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of Series A Preferred Stock and common stock warrants, net of offering costs
Issuance of common stock in connection with offering, net of offering costs
Issuance of common stock in connection with exercise of warrants
Issuance of RSUs related to employee separation agreement
|
2019-09-30 |
| 2019-09-04 | 2520.19 | 270.00 | 定期报告 | 2019-08-28 |
| 2019-08-13 | 2493.13 | 未披露 | 定期报告 | 2019-08-13 |
| 2019-08-07 | 2100.33 | 未披露 | 定期报告 | 2019-08-06 |
| 2019-07-26 | 2082.27 | 未披露 | 定期报告 | 2019-07-19 |
| 2019-08-07 | 2073.30 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Issuance of common stock in connection with offering, net of offering costs
Issuance of common stock in connection with exercise of warrants
Issuance of common stock for option exercises
|
2019-06-30 |
| 2019-05-15 | 1899.21 | 未披露 | 定期报告 | 2019-05-13 |
| 2019-04-19 | 1724.48 | 未披露 | 定期报告 | 2019-04-15 |
| 2019-04-01 | 1723.93 | 未披露 | 定期报告 | 2019-04-01 |
| 2019-05-15 | 1709.50 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Vesting of employee restricted stock awards
|
2019-03-31 |
| 2019-03-29 | 1708.93 | 未披露 | 定期报告 | 2019-03-24 |
| 2019-03-29 | 1708.90 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of common stock in connection with offering
Issuance of stock for option exercises
|
2018-12-31 |
| 2018-11-14 | 1708.93 | 未披露 | 定期报告 | 2018-11-09 |
| 2018-11-14 | 1708.90 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-08-07 | 1708.93 | 未披露 | 定期报告 | 2018-08-03 |
| 2018-08-07 | 1708.90 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-04-18 | 1708.93 | 未披露 | 定期报告 | 2018-04-16 |
| 2018-05-10 | 1708.90 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-03-21 | 1708.93 | 未披露 | 定期报告 | 2018-03-13 |
| 2018-03-21 | 1538.50 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of common stock in connection with exercise of warrants, net of offering costs
Issuance of stock for option exercises
Issuance of stock to consultants for services
Vesting of non-employee restricted stock awards
|
2017-12-31 |
| 2017-12-05 | 1538.46 | 未披露 | 定期报告 | 2017-11-28 |
| 2017-11-14 | 1536.83 | 未披露 | 定期报告 | 2017-11-09 |
| 2017-11-14 | 1536.10 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-10 | 1530.92 | 未披露 | 定期报告 | 2017-08-09 |
| 2017-08-10 | 1530.90 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-04-21 | 1530.92 | 未披露 | 定期报告 | 2017-04-17 |
| 2017-05-11 | 1528.80 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-23 | 1528.82 | 未披露 | 定期报告 | 2017-03-22 |
| 2017-03-23 | 1526.90 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock and warrants, net of offering costs
Issuance of stock to consultants for services
Vesting of employee restricted stock awards
Vesting of non-employee restricted stock awards
Shares retired as a result of the 1 for 25 reverse stock split
|
2016-12-31 |
| 2016-11-10 | 1513.50 | 未披露 | 定期报告 | 2016-11-09 |
| 2016-11-10 | 1486.55 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-11 | 1125.13 | 未披露 | 定期报告 | 2016-08-09 |
| 2016-08-11 | 915.69 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-06-09 | 915.47 | 未披露 | 定期报告 | 2016-05-31 |
| 2016-05-12 | 915.41 | 未披露 | 定期报告 | 2016-05-10 |
| 2016-04-18 | 507.48 | 未披露 | 定期报告 | 2016-04-07 |
| 2016-05-12 | 507.50 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-03-04 | 500.33 | 未披露 |
更多>>
In February 2016, we closed a private placement for the sale of an aggregate of 1,518,567 shares of the Company’s common stock for total gross proceeds amount of $2,830,804.
|
2016-02-29 |
| 2016-03-04 | 348.60 | 未披露 |
更多>>
from December 31, 2014 to December 31, 2015
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock and warrants, net of offering costs
Issuance of stock to consultants for services
Employee bonus paid in common stock
On December 18, 2015, the Company effected a 1-for-25 reverse split of its common stock.
|
2015-12-31 |
| 2015-12-14 | 348.55 | 未披露 |
更多>>
On December 18, 2015, the Company effected a 1-for-25 reverse split of its common stock.
|
2015-12-21 |
| 2015-11-20 | 8713.85 | 未披露 | 定期报告 | 2015-11-19 |
| 2015-11-16 | 8708.72 | 未披露 | 定期报告 | 2015-11-02 |
| 2015-11-16 | 7461.80 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-09-04 | 7481.37 | 未披露 | 定期报告 | 2015-09-02 |
| 2015-08-13 | 7375.51 | 未披露 | 定期报告 | 2015-08-03 |
| 2015-08-13 | 7364.20 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-04-30 | 6119.84 | 未披露 | 定期报告 | 2015-04-20 |
| 2015-05-14 | 6111.30 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-03-31 | 6213.03 | 未披露 | 定期报告 | 2015-03-25 |
| 2015-03-26 | 6111.31 | 未披露 | 定期报告 | 2015-03-23 |
| 2015-03-26 | 5165.00 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock for option exercises
Issuance of stock to consultants for services
Employee bonus paid in common stock
Vesting of employee restricted stock awards
|
2014-12-31 |
| 2014-11-12 | 5162.51 | 未披露 | 定期报告 | 2014-11-05 |
| 2014-11-12 | 5114.30 | 未披露 | 定期报告 | 2014-09-30 |
| 2014-07-31 | 5077.91 | 未披露 | 定期报告 | 2014-07-28 |
| 2014-07-31 | 5077.90 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-05-01 | 5075.70 | 未披露 | 定期报告 | 2014-04-28 |
| 2014-04-25 | 5082.15 | 未披露 | 定期报告 | 2014-04-23 |
| 2014-05-01 | 5070.50 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-03-06 | 4540.75 | 未披露 | 定期报告 | 2014-03-03 |
| 2014-03-06 | 4462.40 | 未披露 |
更多>>
from December 31, 2012 to December 31, 2013
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock to Pioneer
Issuance of stock to Feichter
Credits on sales of NeutroPhase
Issuance of stock for option exercises
Issuance of stock for warrant exercises
Issuance of stock to consultants for services
|
2013-12-31 |
| 2013-11-14 | 3939.77 | 未披露 | 定期报告 | 2013-11-11 |
| 2013-11-14 | 3865.10 | 未披露 | 定期报告 | 2013-09-30 |
| 2013-08-01 | 3742.19 | 未披露 | 定期报告 | 2013-07-30 |
| 2013-08-01 | 3735.80 | 未披露 | 定期报告 | 2013-06-30 |
| 2013-05-02 | 3733.08 | 未披露 | 定期报告 | 2013-04-29 |
| 2013-04-24 | 3731.90 | 未披露 | 定期报告 | 2013-04-19 |
| 2013-05-02 | 3724.10 | 未披露 | 定期报告 | 2013-03-31 |
| 2013-03-14 | 3699.41 | 未披露 | 定期报告 | 2013-03-11 |
| 2013-03-14 | 3691.50 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Issuance of common stock and warrants in connection with shelf offering, net of offering costs
Issuance of stock and warrants in connection with international distribution agreement
Conversion of liablity to equity
Issuance of stock for option exercises
Issuance of stock for warrant exercises
Issuance of stock for services
Issuance of restricted stock awards for employee services
Stock-based compensation expense related to non-employee stock options
|
2012-12-31 |
| 2012-11-01 | 2984.10 | 未披露 | 定期报告 | 2012-10-29 |
| 2012-11-01 | 2974.70 | 未披露 | 定期报告 | 2012-09-30 |
| 2012-08-09 | 2895.94 | 未披露 | 定期报告 | 2012-08-06 |
| 2012-08-09 | 2886.80 | 未披露 | 定期报告 | 2012-06-30 |
| 2012-05-03 | 2894.06 | 未披露 | 定期报告 | 2012-04-30 |
| 2012-05-03 | 2882.70 | 未披露 | 定期报告 | 2012-03-31 |
| 2012-03-27 | 2891.66 | 未披露 | 定期报告 | 2012-03-16 |
| 2012-03-27 | 2858.70 | 未披露 |
更多>>
from December 31, 2010 to December 31, 2011
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock for option exercises
Issuance of stock for services
Issuance of restricted Stock awards for employee services
|
2011-12-31 |
| 2011-11-07 | 2831.68 | 未披露 | 定期报告 | 2011-11-01 |
| 2011-11-07 | 2833.20 | 未披露 | 定期报告 | 2011-09-30 |
| 2011-08-10 | 2813.44 | 未披露 | 定期报告 | 2011-08-01 |
| 2011-08-10 | 2348.40 | 未披露 | 定期报告 | 2011-06-30 |
| 2011-05-16 | 2344.98 | 未披露 | 定期报告 | 2011-05-02 |
| 2011-05-16 | 2345.00 | 未披露 | 定期报告 | 2011-03-31 |
| 2011-03-10 | 2343.98 | 未披露 | 定期报告 | 2011-03-01 |
| 2011-03-10 | 2339.20 | 未披露 |
更多>>
From Dec 31 2009 to December 31, 2010
Issuance of stock for option exercises
Stock-based compensation expense related to non-employee stock and stock options
|
2010-12-31 |
| 2010-11-12 | 2333.59 | 未披露 | 定期报告 | 2010-11-10 |
| 2010-11-12 | 2333.50 | 未披露 | 定期报告 | 2010-09-30 |
| 2010-08-12 | 2333.54 | 未披露 | 定期报告 | 2010-08-09 |
| 2010-08-12 | 2333.40 | 未披露 | 定期报告 | 2010-06-30 |
| 2010-05-12 | 2330.92 | 未披露 | 定期报告 | 2010-05-07 |
| 2010-05-12 | 2330.60 | 未披露 | 定期报告 | 2010-03-31 |
From December 31,2022 to December 31,2023
Vesting of director restricted stock awards
Conversion of Series B Preferred Stock to common stock
Conversion of Series C Preferred Stock to common stock
Issuance of common stock in connection with 2023 Warrant Reprice Transaction, net of offering costs
From June 30, 2023 to September 30, 2023
Conversion of Series B Preferred Stock to common stock
From March 31, 2023 to June 30, 2023
Vesting of director restricted stock awards
Conversion of Series B Preferred Stock to common stock
Conversion of Series C Preferred Stock to common stock
From December 31, 2021 to December 31, 2022
Issuance of Series C Preferred Stock, net of offering costs
Vesting of director restricted stock awards
Shares issued for reverse stock split due to rounding feature
Issuance of common stock in connection with exercise of warrants, net of offering costs
Conversion of Series B Preferred Stock to common stock
Conversion of Series C Preferred Stock to common stock
NovaBay Pharmaceuticals, Inc. announces 1-for-35 reverse stock split.
From June 30, 2022 to September 30, 2022
Exercise of warrants, net of offering costs
From March 31, 2022 to June 30, 2022
Conversion of Series B Non-Voting Preferred Stock to common stock
Vesting of director restricted stock awards
From December 31, 2021 to March 31, 2022
Conversion of Series B Non-Voting Preferred Stock to common stock
From December 31, 2020 to December 31, 2021
Issuance of common stock, net of offering costs
Vesting of employee restricted stock awards
Issuance of RSUs to non-employees for services
Issuance of Series B Preferred Stock and common stock warrants, net of offering costs
Conversion of Series B Preferred Stock to common stock
From June 30, 2021 to September 30, 2021
Vesting of employee restricted stock awards
From March 31, 2021 to June 30, 2021
Issuance of common stock, net of offering costs
Vesting of employee restricted stock awards
From December 31, 2019 to December 31, 2020
Issuance of common stock, net of offering costs
Issuance of common stock in connection with exercise of warrants, net
Issuance of RSUs to non-employees for services
Issuance of stock for option exercises
Vesting of employee restricted stock awards
From June 30, 2020 to September 30, 2020
Issuance of common stock in connection with exercise of warrants, net
Issuance of RSUs to non-employees for services
Issuance of stock for option exercises
From March 31, 2020 to June 30, 2020
Issuance of common stock, net of offering costs
Issuance of common stock in connection with exercise of warrants
From December 31, 2019 to March 31, 2020
Issuance of common stock in connection with exercise of warrants, net of issuance cost
Vesting of employee restricted stock awards
From December 31, 2018 to December 31, 2019
Issuance of Series A Preferred Stock and common stock warrants, net of offering costs
Conversion of Series A Preferred Stock to common stock
Issuance of common stock in connection with offering, net of offering costs
Issuance of common stock in connection with exercise of warrants
Issuance of RSUs related to employee separation agreement
Issuance of common stock for option exercises
Issuance of RSUs to non-employees for services
Vesting of employee restricted stock awards
from June 30, 2019 to September 30, 2019
Issuance of Series A Preferred Stock and common stock warrants, net of offering costs
Issuance of common stock in connection with offering, net of offering costs
Issuance of common stock in connection with exercise of warrants
Issuance of RSUs related to employee separation agreement
from March 31, 2019 to June 30,2019
Issuance of common stock in connection with offering, net of offering costs
Issuance of common stock in connection with exercise of warrants
Issuance of common stock for option exercises
from December 31, 2018 to March 31, 2019
Vesting of employee restricted stock awards
from December 31, 2017 to December 31, 2018
Issuance of common stock in connection with offering
Issuance of stock for option exercises
from December 31, 2016 to December 31, 2017
Issuance of common stock in connection with exercise of warrants, net of offering costs
Issuance of stock for option exercises
Issuance of stock to consultants for services
Vesting of non-employee restricted stock awards
from December 31, 2015 to December 31, 2016
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock and warrants, net of offering costs
Issuance of stock to consultants for services
Vesting of employee restricted stock awards
Vesting of non-employee restricted stock awards
Shares retired as a result of the 1 for 25 reverse stock split
In February 2016, we closed a private placement for the sale of an aggregate of 1,518,567 shares of the Company’s common stock for total gross proceeds amount of $2,830,804.
from December 31, 2014 to December 31, 2015
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock and warrants, net of offering costs
Issuance of stock to consultants for services
Employee bonus paid in common stock
On December 18, 2015, the Company effected a 1-for-25 reverse split of its common stock.
On December 18, 2015, the Company effected a 1-for-25 reverse split of its common stock.
from December 31, 2013 to December 31, 2014
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock for option exercises
Issuance of stock to consultants for services
Employee bonus paid in common stock
Vesting of employee restricted stock awards
from December 31, 2012 to December 31, 2013
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock to Pioneer
Issuance of stock to Feichter
Credits on sales of NeutroPhase
Issuance of stock for option exercises
Issuance of stock for warrant exercises
Issuance of stock to consultants for services
from December 31, 2011 to December 31, 2012
Issuance of common stock and warrants in connection with shelf offering, net of offering costs
Issuance of stock and warrants in connection with international distribution agreement
Conversion of liablity to equity
Issuance of stock for option exercises
Issuance of stock for warrant exercises
Issuance of stock for services
Issuance of restricted stock awards for employee services
Stock-based compensation expense related to non-employee stock options
from December 31, 2010 to December 31, 2011
Issuance of common stock in connection with shelf offering, net of offering costs
Issuance of stock for option exercises
Issuance of stock for services
Issuance of restricted Stock awards for employee services
From Dec 31 2009 to December 31, 2010
Issuance of stock for option exercises
Stock-based compensation expense related to non-employee stock and stock options